World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
144
Citations
83735
World Ranking
1435
National Ranking
837

Michael G. Shlipak publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael G. Shlipak sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 738 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael G. Shlipak D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael G. Shlipak sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 144 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael G. Shlipak is affiliated with the University of California, San Francisco in the United States. Their research primarily spans the field of medicine, with a strong focus on nephrology, cardiology and cardiovascular medicine, pulmonary and respiratory medicine, physiology, and endocrinology, diabetes, and metabolism.

The main topics addressed in their work include chronic kidney disease and diabetes, dialysis and renal disease management, blood pressure and hypertension studies, acute kidney injury research, heart failure treatment and management, diabetes treatment and management, and renal diseases and glomerulopathies.

Shlipak has contributed to several key publications, with recent notable papers including:

  • KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024), Kidney International
  • Development and Validation of the American Heart Association's PREVENT Equations (2023), Circulation
  • The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference (2020), Kidney International
  • Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes (2023), JAMA
  • The Promise of Tubule Biomarkers in Kidney Disease: A Review (2021), American Journal of Kidney Diseases

Frequent co-authors in Shlipak's research include Joachim H. Ix, Michelle M. Estrella, Ronit Katz, Rebecca Scherzer, and Orlando M. Gutiérrez.

The scientist's publications frequently appear in prominent venues such as the Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Kidney Medicine, Clinical Journal of the American Society of Nephrology, and Kidney360.

Best Publications

  • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

    Kunihiro Matsushita;Marije van der Velde;Brad C. Astor;Mark Woodward

  • Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease

    A Levin;PE Stevens;RW Bilous;J Coresh

  • Cystatin C and the risk of death and cardiovascular events among elderly persons.

    Michael G. Shlipak;Mark J. Sarnak;Ronit Katz;Linda F. Fried

  • Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis

    Steven G. Coca;Bushra Yusuf;Bushra Yusuf;Michael G. Shlipak;Michael G. Shlipak;Amit X. Garg

  • Renal Impairment and Outcomes in Heart Failure: Systematic Review and Meta-Analysis

    Grace L. Smith;Judith H. Lichtman;Michael B. Bracken;Michael G. Shlipak;Michael G. Shlipak

  • New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.

    Lesley A Inker;Nwamaka D Eneanya;Josef Coresh;Hocine Tighiouart

  • Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency

    Michael G. Shlipak;Linda F. Fried;Casey Crump;Anthony J. Bleyer

  • Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain.

    John G. Canto;Michael G. Shlipak;William J. Rogers;Judith A. Malmgren

  • Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

    Jacqueline Neuhaus;David R. Jacobs;Jason V. Baker;Jason V. Baker;Alexandra Calmy

  • Cystatin C versus creatinine in determining risk based on kidney function.

    Michael G. Shlipak;Kunihiro Matsushita;Johan Ärnlöv;Johan Ärnlöv;Lesley A. Inker

  • New loci associated with kidney function and chronic kidney disease

    Anna Köttgen;Anna Köttgen;Cristian Pattaro;Carsten A. Böger;Christian Fuchsberger

  • Cardiovascular Mortality Risk in Chronic Kidney Disease: Comparison of Traditional and Novel Risk Factors

    Michael G. Shlipak;Linda F. Fried;Mary Cushman;Teri A. Manolio

  • Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.

    Kunihiro Matsushita;Josef Coresh;Yingying Sang;John Chalmers

  • Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease

    Michael G. Shlipak;Ronit Katz;Mark J. Sarnak;Linda F. Fried

  • Multiple loci associated with indices of renal function and chronic kidney disease

    Anna Köttgen;Nicole L. Glazer;Abbas Dehghan;Shih Jen Hwang

  • Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.

    Michael G. Shlipak;Paul A. Heidenreich;Haruko Noguchi;Glenn M. Chertow

  • Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study

    Alan S. Go;Jingrong Yang;Lynn M. Ackerson;Krista Lepper

  • Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals.

    Linda F. Fried;Michael G. Shlipak;Michael G. Shlipak;Casey Crump;Richard A. Kronmal

  • Cardiovascular Mortality Risk in Chronic Kidney Disease: Comparison of Traditional and Novel Risk Factors

    M.G. Shlipak;L.F. Fried;M. Cushman

  • Cystatin C and the Risk of Death and Cardiovascular Events Among Elderly Persons

    M.G. Shilpak;M.J. Sarnak;R. Katz

Frequent Co-Authors

Joachim H. Ix
Joachim H. Ix University of California, San Diego
Ronit Katz
Ronit Katz University of Washington
Mark J. Sarnak
Mark J. Sarnak Tufts Medical Center
Carmen A. Peralta
Carmen A. Peralta University of California, San Francisco
David S. Siscovick
David S. Siscovick University of Washington
Linda F. Fried
Linda F. Fried University of Pittsburgh
Chirag R. Parikh
Chirag R. Parikh Johns Hopkins University
Anne B. Newman
Anne B. Newman University of Pittsburgh
Carl Grunfeld
Carl Grunfeld University of California, San Francisco
Bryan Kestenbaum
Bryan Kestenbaum University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA but are looking for flexible alternatives, online health-related degrees offer diverse career pathways. Many students seek practical programs that help them rapidly enter the workforce or advance their careers, especially through online or accelerated learning options.

For those interested in nursing, a 6 month lpn program can be a quick and efficient route to becoming a licensed practical nurse. If you want to specialize further, the fastest psychiatric nurse practitioner program can provide advanced training in mental health in less time than traditional degrees.

For working professionals, a dnp program without clinical hours may offer the flexibility needed to earn a Doctor of Nursing Practice without the demands of on-site clinical placements. Meanwhile, those interested in the managerial side of healthcare may want to consider a healthcare administration degree online, an affordable option that leads to leadership roles in healthcare organizations.

Best Scientists Citing Michael G. Shlipak

Trending Scientists

Recently Published Articles